Oregon Public Employees Retirement Fund’s Supernus Pharmaceuticals SUPN Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$613K	Buy	13,170 +25	+0.2%	+$1.2K	0.01%	1165
2026 Q1	$679K	Hold	13,145	–	–	0.01%	1055
2025 Q4	$653K	Buy	13,145 +547	+4%	+$26.6K	0.01%	1056
2025 Q3	$602K	Sell	12,598 -200	-2%	-$8.05K	0.01%	1069
2025 Q2	$403K	Buy	12,798 +100	+0.8%	+$3.21K	0.01%	1190
2025 Q1	$416K	Sell	12,698 -300	-2%	-$10.6K	0.01%	1175
2024 Q4	$470K	Hold	12,998	–	–	0.01%	1183
2024 Q3	$405K	Sell	12,998 -300	-2%	-$9.36K	0.01%	1225
2024 Q2	$356K	Sell	13,298 -1,300	-9%	-$37.7K	0.01%	1237
2024 Q1	$498K	Sell	14,598 -1,400	-9%	-$41.7K	0.01%	1160
2023 Q4	$463K	Sell	15,998 -255	-2%	-$6.76K	0.01%	1245
2023 Q3	$448K	Sell	16,253 -700	-4%	-$21.3K	0.01%	1318
2023 Q2	$510K	Sell	16,953 -400	-2%	-$14K	0.01%	1300
2023 Q1	$629K	Sell	17,353 -250	-1%	-$9.61K	0.01%	1210
2022 Q4	$628K	Sell	17,603 -30	-0.2%	-$1.04K	0.01%	1202
2022 Q3	$597K	Buy	17,633 +225	+1%	+$7.32K	0.01%	1178
2022 Q2	$503K	Sell	17,408 -2,700	-13%	-$77.3K	0.01%	1124
2022 Q1	$650K	Sell	20,108 -500	-2%	-$15.3K	0.01%	1297
2021 Q4	$601K	Sell	20,608 -1,000	-5%	-$30.3K	0.01%	1236
2021 Q3	$576K	Sell	21,608 -100	-0.5%	-$2.68K	0.01%	1252
2021 Q2	$668K	Hold	21,708	–	–	0.01%	1213
2021 Q1	$568K	Buy	21,708 +400	+2%	+$11.2K	0.01%	1271
2020 Q4	$536K	Sell	21,308 -331	-2%	-$7.12K	0.01%	1211
2020 Q3	$451K	Buy	21,639 +600	+3%	+$13.6K	0.01%	1154
2020 Q2	$500K	Hold	21,039	–	–	0.01%	1108
2020 Q1	$378K	Hold	21,039	–	–	0.01%	1133
2019 Q4	$499K	Hold	21,039	–	–	0.01%	1213
2019 Q3	$578K	Buy	21,039 +400	+2%	+$11.9K	0.01%	1203
2019 Q2	$683K	Buy	20,639 +400	+2%	+$13.7K	0.01%	1145
2019 Q1	$709K	Buy	20,239 +366	+2%	+$13.6K	0.01%	1112
2018 Q4	$660K	Buy	+19,873	New	+$855K	0.01%	1090

Other funds holding SUPN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Oregon Public Employees Retirement Fund's SUPN Position: Q2 2026 in Review

Oregon Public Employees Retirement Fund increased its Supernus Pharmaceuticals (SUPN) stake by 0.19% in Q2 2026, buying an estimated $1.2K and bringing the position to 13,170 shares worth $613K. The position accounts for 0.01% of the portfolio, ranked #1165.

Oregon Public Employees Retirement Fund first reported a position in SUPN in Q4 2018 and has held it in 31 quarters since. The position peaked at $709K in Q1 2019. 131 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

Oregon Public Employees Retirement Fund held 13,170 shares of Supernus Pharmaceuticals worth $613K as of Q2 2026.
Oregon Public Employees Retirement Fund bought 25 Supernus Pharmaceuticals shares in Q2 2026, an estimated $1.2K.
Supernus Pharmaceuticals made up 0.01% of Oregon Public Employees Retirement Fund's portfolio in Q2 2026, its #1165 holding.
Oregon Public Employees Retirement Fund first reported a position in Supernus Pharmaceuticals in Q4 2018 and has held it in 31 quarters since.
Oregon Public Employees Retirement Fund's Supernus Pharmaceuticals position peaked at $709K in Q1 2019.
131 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.